Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Antengene Corporation Limited ( (HK:6996) ) just unveiled an announcement.
Antengene Corporation Limited announced that all proposed resolutions at its Annual General Meeting held on June 13, 2025, were successfully passed. These resolutions included the approval of financial statements, re-election of directors, re-appointment of auditors, and granting of mandates for share issuance and repurchase. The outcomes of the AGM reflect strong shareholder support and are likely to impact the company’s strategic direction and operational capabilities positively.
The most recent analyst rating on (HK:6996) stock is a Hold with a HK$1.06 price target. To see the full list of analyst forecasts on Antengene Corporation Limited stock, see the HK:6996 Stock Forecast page.
More about Antengene Corporation Limited
Antengene Corporation Limited is a biopharmaceutical company focused on innovative oncology therapies. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 5,206,862
Technical Sentiment Signal: Hold
Current Market Cap: HK$2.63B
See more insights into 6996 stock on TipRanks’ Stock Analysis page.